{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-019798","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2023-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.169111+00:00","generated_at":"2026-06-14T09:01:43.097014+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Nephros annual meeting: Harris elected, auditor ratified, say-on-pay approved","bullets":["Joseph Harris elected director with 5,333,628 votes for (term expires 2026).","Baker Tilly US, LLP ratified as auditor for FY2023: 8,622,127 for, 9,252 against.","Non-binding advisory vote on NEO compensation passed: 5,309,669 for, 885,868 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-019798","json":"https://secwatch.observer/filing/0001493152-23-019798.json","markdown":"https://secwatch.observer/filing/0001493152-23-019798.md","text":"https://secwatch.observer/filing/0001493152-23-019798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223019798/0001493152-23-019798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223019798/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T09:01:43.097014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e717dac3fbf007a9b83d0db42251a67bc5294bc","claim":"NEPHROS INC shareholders approved Ratification of the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-01 meeting.","evidence_excerpt":"Stockholders ratified the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223019798/0001493152-23-019798-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"},{"claim_id":"205a69e415124da17b7277c96ee3897bdad4a24d","claim":"NEPHROS INC shareholders approved Election of Director at the 2023-06-01 meeting.","evidence_excerpt":"Stockholders elected to the Company’s Board of Directors one nominee, Joseph Harris, to serve a three-year term expiring in 2026","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223019798/0001493152-23-019798-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"},{"claim_id":"5a0c0a5d1da15058fc826b31bd577c542025eb3b","claim":"NEPHROS INC shareholders approved Approval of the compensation of the Company’s named executive officers on an advisory (non-binding) basis at the 2023-06-01 meeting.","evidence_excerpt":"Stockholders approved the compensation of the Company’s named executive officers on an advisory (non-binding) basis","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223019798/0001493152-23-019798-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-01"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}